Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.22% | 17.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 35.05% | 8.81% | |||
| Operating Income | -35.05% | -8.81% | |||
| Income Before Tax | -31.01% | -11.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.01% | -11.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.01% | -11.31% | |||
| EBIT | -35.05% | -8.81% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 19.69% | -11.18% | |||
| Normalized Basic EPS | 19.67% | -11.15% | |||
| EPS Diluted | 19.69% | -11.18% | |||
| Normalized Diluted EPS | 19.67% | -11.15% | |||
| Average Basic Shares Outstanding | 63.13% | 0.12% | |||
| Average Diluted Shares Outstanding | 63.13% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||